These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10389713)

  • 1. Cost-effectiveness of estimating gestational age by ultrasonography in Down syndrome screening.
    Benn PA; Rodis JF; Beazoglou T
    Obstet Gynecol; 1999 Jul; 94(1):29-33. PubMed ID: 10389713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compromise ultrasound dating policy in maternal serum screening for Down syndrome.
    Rahim RR; Cuckle HS; Sehmi IK; Jones RG
    Prenat Diagn; 2002 Dec; 22(13):1181-4. PubMed ID: 12478629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.
    Benn PA; Borgida A; Horne D; Briganti S; Collins R; Rodis JF
    Am J Obstet Gynecol; 1997 May; 176(5):1056-61. PubMed ID: 9166168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic evaluation of first-trimester genetic sonography for prenatal detection of Down syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T
    Obstet Gynecol; 1998 Apr; 91(4):535-9. PubMed ID: 9540936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined second-trimester biochemical and ultrasound screening for Down syndrome.
    Benn PA; Kaminsky LM; Ying J; Borgida AF; Egan JF
    Obstet Gynecol; 2002 Dec; 100(6):1168-76. PubMed ID: 12468159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of prenatal screening for Down syndrome in the U.S.A.
    Beazoglou T; Heffley D; Kyriopoulos J; Vintzileos A; Benn P
    Prenat Diagn; 1998 Dec; 18(12):1241-52. PubMed ID: 9885015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic evaluation of second-trimester genetic ultrasonography for prenatal detection of down syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    Am J Obstet Gynecol; 1998 Nov; 179(5):1214-9. PubMed ID: 9822503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of gestational age estimation from last menstrual period among women seeking abortion in South Africa, with a view to task sharing: a mixed methods study.
    Constant D; Harries J; Moodley J; Myer L
    Reprod Health; 2017 Aug; 14(1):100. PubMed ID: 28830534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The research implications of the selection of a gestational age estimation method.
    Lynch CD; Zhang J
    Paediatr Perinat Epidemiol; 2007 Sep; 21 Suppl 2():86-96. PubMed ID: 17803622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    Am J Obstet Gynecol; 1999 May; 180(5):1227-33. PubMed ID: 10329882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.